1. Mendelian
  2. Experts
  3. MULTIPLE MYELOMA Experts by country

MULTIPLE MYELOMA Experts

We have collected the completed list of expert related to MULTIPLE MYELOMA using public data available on different databases.

MULTIPLE MYELOMA Experts map



If you find this map or researchers for MULTIPLE MYELOMA useful, maybe you will be also interested in other rare diseases proffesionals like our amyotrophic lateral sclerosis expert list ,or our huntington disease expert list

MULTIPLE MYELOMA Experts list

Dr Wolfgang WILLENBACHER

 INNSBRUCK. AUSTRIA

  Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project - Manager of registry - Coordinator of research network - Quality manager

  • Research area/topic:
    OPTATIO: OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma
  • OeGHO Geschäftsstelle
    Medizinische Universität Innsbruck
  • wolfgang.w***********@***ol_kliniken.at
Complete Info

Dr Wolfgang WILLENBACHER

 WIEN. AUSTRIA

  Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project - Manager of registry - Coordinator of research network - Quality manager

  • Research area/topic:
    OPTATIO: OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma
  • OeGHO Geschäftsstelle
    Medizinische Universität Innsbruck
  • wolfgang.w***********@***ol_kliniken.at
Complete Info

Pr Heinz GISSLINGER

 WIEN. AUSTRIA

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project - Coordinator of multinational clinical trial

  • Research area/topic:
    Multicenter Non-interventional Study to Investigate Drug Utilization of Pomalidomide in Clinical Practice for the Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) - AT
  • Universitätsklinik für Innere Medizin I, Allgemeines Krankenhaus der Stadt Wien
    Medizinische Universität Wien
  • heinz.gi********@***uniwien.ac.at
Complete Info

Pr Karin VANDERKERKEN

 BRUSSELS. BELGIUM

  Investigator of research project - Coordinator of research network

  • Research area/topic:
    OVER-MYR: Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
  • Universitair Ziekenhuis Brussel - UZ Brussel
  • karin.van*********@***.ac.be
Complete Info

Pr Bernard THEBAUD

 TORONTO. CANADA

  Investigator of research project

  • Research area/topic:
    A small molecule inhibitor of G protein-coupled Receptor Kinase 6 (GRK6) to treat human Multiple Myeloma and related diseases
  • Biomedicine Institute, University of Turku
    Toronto General Hospital
  • bthe****@***berta.ca
Complete Info

Pr Bernard THEBAUD

 TURKU. FINLAND

  Investigator of research project

  • Research area/topic:
    A small molecule inhibitor of G protein-coupled Receptor Kinase 6 (GRK6) to treat human Multiple Myeloma and related diseases
  • Biomedicine Institute, University of Turku
    Toronto General Hospital
  • bthe****@***berta.ca
Complete Info

Pr Antonio PEZZUTTO

 BERLIN. GERMANY

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project

  • Research area/topic:
    MAGEA1-TCR : MAGE-A1 TCR gene therapy of Multiple Myeloma as an example
  • CharitéCentrum (CC) für Tumormedizin, Charité - Universitätsmedizin Berlin (CVK)
  • antonio.********@***rite.de
Complete Info

Pr Martin EILERS

 WÜRZBURG. GERMANY

  Investigator of research project - Director of laboratory

  • Research area/topic:
    Characterization of the Oncogenic Signaling Network in Multiple Myeloma - Development of Targeted Therapies (KFO 216): Systemic shRNA screens and high throughout sequencing to investigate pathway dependence in multiple myeloma
  • Theodor-Boveri-Institut für Biowissenschaften, Universität Würzburg - Biozentrum
  • martin*******@***zentrum.uni_wuerzburg.de
Complete Info

Dr Sérgio J DIAS

 LISBOA. PORTUGAL

  Investigator of research project

  • Research area/topic:
    Exploiting the molecular basis underlying an aberrant vascular niche in Multiple myeloma
  • Faculdade de Ciências Médicas - Universidade Nova de Lisboa, Centro de Estudos de Doenças Crónicas
Complete Info

Dr Carlos FERNÁNDEZ DE LARREA RODRÍGUEZ

 BARCELONA. SPAIN

  Coordinator of expert centre - Clinical expert - Investigator of clinical trial - Investigator of research project

  • Research area/topic:
    Mechanisms of immunological control involved in the progression after treatment in multiple myeloma
  • Hospital Clínic de Barcelona
    Área de oncología y hematología, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
  • cfer****@***nic.ub.es
Complete Info

Dr Joaquín MARTÍNEZ LÓPEZ

 MADRID. SPAIN

  Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project

  • Research area/topic:
    New generation strategies for the global molecular characterization of the multiple myeloma tumor clone: implications in clinical diagnosis and pathogenesis of the disease
  • Hospital Universitario 12 de Octubre
    Área de cáncer, Instituto de Investigación Hospital 12 de Octubre
Complete Info

Dr Juan José LAHUERTA PALACIOS

 MADRID. SPAIN

  Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project

  • Research area/topic:
    Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)
  • Hospital Universitario 12 de Octubre
    Área de cáncer, Instituto de Investigación Hospital 12 de Octubre
Complete Info

Pr Jesús SAN MIGUEL IZQUIERDO

 PAMPLONA. SPAIN

  Principal investigator of clinical trial - Investigator of research project - Coordinator of research network - Director of department

  • Research area/topic:
    Multiple myeloma and other gammopathies
  • Complejo Asistencial Universitario de Salamanca
    Clínica Universidad de Navarra
    Centro de Investigación del Cáncer (USAL-CSIC)
  • sanm*****@***v.es
Complete Info

Dr Xabier AGUIRRE ENA

 PAMPLONA. SPAIN

  Investigator of research project

  • Research area/topic:
    Detection and functional validation of the long non-coding RNAs specific in plasma cell in Multiple Myeloma
  • Programa de Oncohematología, CIMA - Centro de Investigación Médica Aplicada
Complete Info

Dr Patricia MAISO CASTELLANOS

 PAMPLONA. SPAIN

  Investigator of research project

  • Research area/topic:
    Evaluation of 18F-FDG, 11C-MET and 11C-COL for the detection of tumor infiltration in Multiple Myeloma (MM): Translational study in preclinical and clinical models in patients (MIELOMAPET)
  • Programa de Oncohematología, CIMA - Centro de Investigación Médica Aplicada
  • pma***@***v.es
Complete Info

Pr Jesús SAN MIGUEL IZQUIERDO

 SALAMANCA. SPAIN

  Principal investigator of clinical trial - Investigator of research project - Coordinator of research network - Director of department

  • Research area/topic:
    Multiple myeloma and other gammopathies
  • Complejo Asistencial Universitario de Salamanca
    Clínica Universidad de Navarra
    Centro de Investigación del Cáncer (USAL-CSIC)
  • sanm*****@***v.es
Complete Info

Dr María Mercedes GARAYOA BERRUETA

 SALAMANCA. SPAIN

  Investigator of research project

  • Research area/topic:
    Regulation of the microenvironment in multiple myeloma via microRNAs: role in the disease and therapeutic possibilities
  • Consejo Superior de Investigaciones Científicas - Universidad de Salamanca, Centro de Investigación del Cáncer (USAL-CSIC)
  • mgar****@***l.es
Complete Info

Dr Javier DE LAS RIVAS

 SALAMANCA. SPAIN

  Investigator of research project

  • Research area/topic:
    Genomics and integrative proteomics of myeloid malignancies and multiple myeloma: bioinformatic study of omic data from clinical samples to identify markers of prognosis, response and survival, and effective stratification of patients
  • Centro de Investigación del Cáncer (USAL-CSIC)
  • jri***@***l.es
Complete Info

Dr Ramón GARCÍA SANZ

 SALAMANCA. SPAIN

  Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project

  • Research area/topic:
    New generation strategies for the global molecular characterization of the multiple myeloma tumor clone: implications in clinical diagnosis and pathogenesis of the disease
  • Complejo Asistencial Universitario de Salamanca
    IBSAL - Instituto de Investigación Biomédica de Salamanca
  • rgar****@***l.es
Complete Info

Dr María Victoria MATEOS MANTECA

 SALAMANCA. SPAIN

  Principal investigator of clinical trial - Investigator of clinical trial - Investigator of research project

  • Research area/topic:
    Ultra-sensitive evaluation of residual disease as a biomarker of curability in two models of multiple myeloma
  • Complejo Asistencial Universitario de Salamanca
    IBSAL - Instituto de Investigación Biomédica de Salamanca
  • mvma****@***l.es
Complete Info

Dr Enrique M OCIO SAN MIGUEL

 SALAMANCA. SPAIN

  Principal investigator of clinical trial - Investigator of research project

  • Research area/topic:
    Preclinical evaluation of anti-myeloma drug resistance mechanisms (Proteasome and Immunomodulatory Inhibitors) and development of strategies to overcome it
  • Complejo Asistencial Universitario de Salamanca
    IBSAL - Instituto de Investigación Biomédica de Salamanca
  • emo***@***l.es
Complete Info

Dr Norma Carmen GUTIÉRREZ GUTIÉRREZ

 SALAMANCA. SPAIN

  Investigator of research project

  • Research area/topic:
    Study of the functional status of p53 in multiple myeloma and its impact on the therapeutic response and survival of patients
  • Complejo Asistencial Universitario de Salamanca
    IBSAL - Instituto de Investigación Biomédica de Salamanca
  • nor****@***l.es
Complete Info

Pr Helena JERNBERG-WIKLUND

 . SWEDEN

  Investigator of research project

  • Research area/topic:
    Targeting the insulin like growth factor (IGF-1) and interferon (IFN) signaling pathways in apoptosis sensitization - implications for biology and therapy of multiple myeloma
  • Uppsala Universitet
Complete Info

Institution: Information not provided - UK

 NYI UK. UNITED KINGDOM

 

  • Research area/topic:
    Carfilzomib in combination with dexamethasone for treating multiple myeloma [ID934]
  • Institution: Information not provided - UK
Complete Info

Other experts list that you may find interesting:

All the contact information provided is based on public data available in orpha.net.